– USA, NJ – Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, announced the appointment of Shanth Thiyagalingam to its Board of Directors, effective May 14, 2025, bringing more than 20 years of global leadership in commercial scaling, product innovation, and strategic execution across the medical device and pharmaceutical industries.
About Shanth Thiyagalingam
Shanth Thiyagalingam serves as COO of PainTEQ, a manufacturer of proprietary medical equipment focused on interventional pain therapy. From 2020 through 2025, he held successive leadership roles at the company—from CCO to COO, and ultimately as CEO. During his tenure, he led the company’s transformation from early-stage startup to hyper-growth innovator in the interventional pain space. He also led M&A initiatives and was instrumental in securing a Category 1 CPT code for the LinQ procedure—a new therapy in the interventional pain market. Under his leadership, PainTEQ was recognized three years in a row by the Inc. 5000 and named a “Best Place to Work” by the Tampa Bay Business Journal.
Previously, he served as General Manager of APAC Neuromodulation at Abbott, overseeing commercial strategy and operations across Australia, New Zealand, Japan, and the broader Asia-Pacific region. He launched the APAC Neuromodulation Program, led regional expansion into China, Taiwan, and India, and introduced the Japan Proclaim system. Before that, as Regional Director at Nevro, he doubled division revenue and contributed to the successful U.S. launch of the HF10 therapy.
Earlier in his career, Mr. Thiyagalingam held senior roles at Stryker, where he led the strategic growth of the trauma division across Australia and integrated key acquisitions, and at St. Jude Medical, where he managed cardiac and electrophysiology portfolios, delivering multiple product launches across EMEA and Asia Pacific. He began his career at Bristol Myers Squibb and Boehringer Ingelheim, earning national recognition for sales excellence in virology and primary care.
Shanth Thiyagalingam holds a Bachelor of Medical Science from the University of Sydney, a Master’s in Marketing Management, and an MBA from Macquarie Graduate School of Management. He is also a certified Gallup Strengths Coach and is passionate about fostering high-performance cultures and mentoring emerging leaders in the medtech industry.
About Milestone Scientific Inc.
Milestone Scientific Inc. is a technology-focused medical research and development company that patents, designs, and develops innovative injection technologies and instruments for medical and dental applications. Milestone Scientific’s computer-controlled systems are designed to make injections precise, efficient, and increase the overall patient comfort and safety. The Company leverages its proprietary DPS Dynamic Pressure Sensing Technology platform to advance the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions of subcutaneous drug delivery, including local anesthetics.
For more information: https://www.milestonescientific.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.